| Product Information |
DR-XY38191_PI_01.pdf
|
| Registration Number |
DR-XY38191
|
| Generic Name |
Ropinirole Hydrochloride
|
| Brand Name |
Requip PD
|
| Dosage Strength |
2 mg
|
| Dosage Form |
Prolonged-Release Tablet
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
Alu/Child-Resistant Blister Pack x 4's (Box of 28's)
|
| Pharmacologic Category |
Anti-Parkinsonism
|
| Manufacturer |
Glaxo Wellcome S.A.
|
| Country of Origin |
Spain
|
| Trader |
N/A
|
| Importer |
GlaxoSmithKline Philippines, Inc.
|
| Distributor |
N/A
|
| Application Type |
Initial (from Monitored Release status) correction
|
| Issuance Date |
21 April 2022
|
| Expiry Date |
08 July 2025
|